|
|
Article: Combined HRT not linked to endometrial hyperplasia. (Long-Term Continuous TX).
- Article from:
- OB GYN News
- Article date:
- September 1, 2002
- Author:
CopyrightCOPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Postmenopausal women who used continuous combined hormone replacement therapy for up to 5 years were not at increased risk for endometrial hyperplasia or malignancy in a prospective, long-term follow-up study.
Moreover, the therapy was associated with some protective benefits, Dr. Michael Wells of the University of Sheffield (England) and his colleagues reported.
After an average duration of 4.4 years of hormone replacement therapy (HRT) use, endometrial histology in 534 postmenopausal women revealed that none of those with an assessable uterus had endometrial hyperplasia or malignancy including 21 who had been diagnosed with complex hyperplasia before ...